182 related articles for article (PubMed ID: 4064557)
21. Differences between hepatic and biliary lipid metabolism and secretion in genetically gallstone-susceptible and gallstone-resistant mice.
Xu G; Zhao L; Fuchs M
Chin Med J (Engl); 2002 Sep; 115(9):1292-5. PubMed ID: 12411097
[TBL] [Abstract][Full Text] [Related]
22. Effect of the type of dietary fat on biliary lipid composition and bile lithogenicity in humans with cholesterol gallstone disease.
Yago MD; González V; Serrano P; Calpena R; Martínez MA; Martínez-Victoria E; Mañas M
Nutrition; 2005 Mar; 21(3):339-47. PubMed ID: 15797676
[TBL] [Abstract][Full Text] [Related]
23. Speed of change in biliary lipids and bile acids with chenodeoxycholic acid--is intermittent therapy feasible?
Iser JH; Murphy GM; Dowling RH
Gut; 1977 Jan; 18(1):7-15. PubMed ID: 838406
[TBL] [Abstract][Full Text] [Related]
24. Chenotherapy for gallstone dissolution. II. Induced changes in bile composition and gallstone response.
Hofmann AF; Thistle JL; Klein PD; Szczepanik PA; Yu PY
JAMA; 1978 Mar; 239(12):1138-44. PubMed ID: 628065
[TBL] [Abstract][Full Text] [Related]
25. Effects of biliary bile acid composition on biliary cholesterol saturation in gallstone patients treated with chenodeoxycholic acid and/or ursodeoxycholic acid.
Stiehl A; Raedsch R; Czygan P; Götz R; Männer C; Walker S; Kommerell B
Gastroenterology; 1980 Dec; 79(6):1192-8. PubMed ID: 7439628
[TBL] [Abstract][Full Text] [Related]
26. Influence of age on secretion of cholesterol and synthesis of bile acids by the liver.
Einarsson K; Nilsell K; Leijd B; Angelin B
N Engl J Med; 1985 Aug; 313(5):277-82. PubMed ID: 4010739
[TBL] [Abstract][Full Text] [Related]
27. Effect of prolonged feeding with chenodeoxycholic acid on bile in patients with and without gallstones.
Bateson MC; Ross PE; Murison J; Bouchier IA
Gut; 1977 Aug; 18(8):599-605. PubMed ID: 330352
[TBL] [Abstract][Full Text] [Related]
28. Effect of oral chenodeoxycholic acid on bile acid kinetics and biliary lipid composition in women with cholelithiasis.
Danzinger RC; Hofmann AF; Thistle JL; Schoenfield LJ
J Clin Invest; 1973 Nov; 52(11):2809-21. PubMed ID: 4583981
[TBL] [Abstract][Full Text] [Related]
29. Influence of cholic and chenodeoxycholic acid on biliary cholesterol secretion in man.
Lindblad L; Lundholm K; Scherstén T
Eur J Clin Invest; 1977 Oct; 7(5):383-8. PubMed ID: 411667
[TBL] [Abstract][Full Text] [Related]
30. Differing effects of ursodeoxycholic or chenodeoxycholic acid on biliary cholesterol saturation and bile acid metabolism in man. A dose-response study.
Thistle JL; Larusso NF; Hofmann AF; Turcotte J; Carlson GL; Ott BJ
Dig Dis Sci; 1982 Feb; 27(2):161-8. PubMed ID: 7075411
[TBL] [Abstract][Full Text] [Related]
31. Interaction of chenodeoxycholic acid and dietary cholesterol in the treatment of cholesterol gallstones.
Doty JE; DenBesten L; Roslyn JJ; Pitt HA; Kuchenbecker SL; Porter-Fink V
Am J Surg; 1982 Jan; 143(1):48-54. PubMed ID: 7053655
[TBL] [Abstract][Full Text] [Related]
32. Resistance to chenodeoxycholic acid (CDCA) treatment in obese patients with gall stones.
Iser JH; Maton PN; Murphy GM; Dowling RH
Br Med J; 1978 Jun; 1(6126):1509-12. PubMed ID: 656777
[TBL] [Abstract][Full Text] [Related]
33. Gallstone prevalence and biliary lipid composition in inflammatory bowel disease.
Marks JW; Conley DR; Capretta TL; Bonorris GG; Chung A; Coyne MJ; Schoenfield LJ
Am J Dig Dis; 1977 Dec; 22(12):1097-100. PubMed ID: 930909
[TBL] [Abstract][Full Text] [Related]
34. Combined bile acid therapy is more effective on biliary lipids and dissolution rates than monotherapy after gallstone lithotripsy.
Tudyka J; Kratzer W; Janowitz P; Mason R; Wechsler JG
Am J Gastroenterol; 1995 Nov; 90(11):1942-8. PubMed ID: 7484996
[TBL] [Abstract][Full Text] [Related]
35. [Biliary lipid secretion in men with cholelithiasis].
Covarrubias C; Antezana C; Severín C; Valdivieso V
Rev Med Chil; 1989 Nov; 117(11):1217-20. PubMed ID: 2519794
[TBL] [Abstract][Full Text] [Related]
36. Lack of response to chenodeoxycholic acid in obese and non-obese patients. Role of cholesterol synthesis and possible response to ursodeoxycholic acid.
Maton PN; Murphy GM; Dowling RH
Gut; 1980 Dec; 21(12):1082-6. PubMed ID: 7461467
[TBL] [Abstract][Full Text] [Related]
37. Biliary lipid composition in obesity.
Angelin B; Einarsson K; Ewerth S; Leijd B
Scand J Gastroenterol; 1981; 16(8):1015-9. PubMed ID: 7336127
[TBL] [Abstract][Full Text] [Related]
38. Physical activity, biliary lipids, and gallstones in obese subjects.
Chuang CZ; Martin LF; LeGardeur BY; Lopez A
Am J Gastroenterol; 2001 Jun; 96(6):1860-5. PubMed ID: 11419840
[TBL] [Abstract][Full Text] [Related]
39. Biliary lipid excretion in patients with pigment gallstones. A comparison with cholesterol gallstone patients.
Wagner CI; Trotman BW; Soloway RD
Am J Dig Dis; 1978 Jan; 23(1):85-8. PubMed ID: 619630
[TBL] [Abstract][Full Text] [Related]
40. Maintenance of hepatic bile acid secretion rate during overnight fasting by bedtime bile acid administration.
Lanzini A; Facchinetti D; Northfield TC
Gastroenterology; 1988 Oct; 95(4):1029-35. PubMed ID: 3410216
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
